Cargando…

Cardiac Resynchronisation Therapy and Cellular Bioenergetics: Effects Beyond Chamber Mechanics

Cardiac resynchronisation therapy is a cornerstone in the treatment of advanced dyssynchronous heart failure. However, despite its widespread clinical application, precise mechanisms through which it exerts its beneficial effects remain elusive. Several studies have pointed to a metabolic component...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoniou, Christos-Konstantinos, Manolakou, Panagiota, Magkas, Nikolaos, Konstantinou, Konstantinos, Chrysohoou, Christina, Dilaveris, Polychronis, Gatzoulis, Konstantinos A, Tousoulis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Radcliffe Cardiology 2019
Materias:	Heart Failure and Arrhythmias
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6523053/ https://www.ncbi.nlm.nih.gov/pubmed/31131035 http://dx.doi.org/10.15420/ecr.2019.2.2

Ejemplares similares

Comparison of left ventricular and biventricular pacing: Rationale and clinical implications
por: Dilaveris, Polychronis, et al.
Publicado: (2019)

Leadless Pacemakers: Current Achievements and Future Perspectives
por: Vouliotis, Apostolos Ilias, et al.
Publicado: (2023)

Measures of endothelial dysfunction predict response to cardiac resynchronisation therapy
por: Warriner, David R, et al.
Publicado: (2016)

Scar burden is an independent and incremental predictor of cardiac resynchronisation therapy response
por: Harb, Serge C, et al.
Publicado: (2019)

Does recovery from submaximal exercise predict response to cardiac resynchronisation therapy?
por: Wouters, Philippe, et al.
Publicado: (2022)

Sodium–glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments
por: Tamargo, Juan
Publicado: (2019)

Insights for Stratification of Risk in Brugada Syndrome
por: Iglesias, Daniel García, et al.
Publicado: (2019)

Signal‐averaged electrocardiography: Past, present, and future
por: Gatzoulis, Konstantinos A., et al.
Publicado: (2018)

Arrhythmic risk stratification in heart failure mid‐range ejection fraction patients with a non‐invasive guiding to programmed ventricular stimulation two‐step approach
por: Arsenos, Petros, et al.
Publicado: (2020)

Prognostic importance of the Controlling Nutritional Status (CONUT) score in patients undergoing cardiac resynchronisation therapy
por: Ikeya, Yukitoshi, et al.
Publicado: (2021)

Three‐dimensional electroanatomically guided slow pathway elimination is associated with procedural improvements and clinical benefit in atrioventricular node reentrant tachycardia patients
por: Tsiachris, Dimitrios, et al.
Publicado: (2022)

Cardiac resynchronisation therapy in paediatric and congenital heart disease: differential effects in various anatomical and functional substrates
por: Janoušek, J, et al.
Publicado: (2009)

Determinants of LV dP/dt(max) and QRS duration with different fusion strategies in cardiac resynchronisation therapy
por: Odland, Hans Henrik, et al.
Publicado: (2021)

Characterisation of circulating biomarkers before and after cardiac resynchronisation therapy and their role in predicting CRT response: the COVERT-HF study
por: McAloon, Christopher J, et al.
Publicado: (2018)

Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
por: Mustafa, Usman, et al.
Publicado: (2019)

Syncope associated with supraventricular tachycardia: Diagnostic role of implantable loop recorders
por: Soulaidopoulos, Stergios, et al.
Publicado: (2021)

Mechanical dyssynchrony is additive to ECG criteria and independently associated with reverse remodelling and clinical response to cardiac resynchronisation therapy in patients with advanced heart failure
por: Bank, Alan J, et al.
Publicado: (2015)

Extracellular cardiac matrix biomarkers in patients with reduced ejection fraction heart failure as predictors of response to cardiac resynchronisation therapy: a systematic review
por: McAloon, Christopher J, et al.
Publicado: (2017)

Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post‐myocardial infarction patients with an ejection fraction ≥40% at risk for sudden cardiac arrest: Insights from the PRESERVE‐EF study
por: Trachanas, Konstantinos, et al.
Publicado: (2021)

Arrhythmic risk stratification in ischemic, non-ischemic and hypertrophic cardiomyopathy: A two-step multifactorial, electrophysiology study inclusive approach
por: Arsenos, Petros, et al.
Publicado: (2022)

Hidden in Heart Failure
por: Cannie, Douglas Ewan, et al.
Publicado: (2019)

Rhythm Control in AF: Have We Reached the Last Frontier?
por: Dan, Gheorghe-Andrei
Publicado: (2019)

Chagas Disease and Heart Failure: An Expanding Issue Worldwide
por: Martinez, Felipe, et al.
Publicado: (2019)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

Permanent pacemaker implantation in unexplained syncope patients with borderline sinus bradycardia and electrophysiology study‐proven sinus node disease
por: Doundoulakis, Ioannis, et al.
Publicado: (2020)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Association of non‐invasive electrocardiographic risk factors with left ventricular systolic function in post‐myocardial infarction patients with mildly reduced or preserved ejection fraction: Insights from the PRESERVE‐EF study
por: Tsimos, Konstantinos P., et al.
Publicado: (2022)

Preoperative Levosimendan therapy reduces postoperative right ventricular failure in patients undergoing left ventricular assist device implantation
por: Sugimura, Yukiharu, et al.
Publicado: (2023)

Extremely reduced COVID-19 mortality in a “Blue Zone”: an observational cohort study
por: Stefanadis, Christodoulos, et al.
Publicado: (2022)

Effect of cardiac resynchronisation therapy in dilated cardiomyopathy
por: Bouwmeester, S., et al.
Publicado: (2021)

Achievement of Right Ventricular Pacing by Use of a Long Guiding Catheter in a Hemodialysis Patient Presenting Significant Tortuosity of Vasculature
por: Dilaveris, Polychronis, et al.
Publicado: (2011)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_v89b6n59q1q4sfgug7l9tmepin